Mithridion raises $1.25 million
Madison biopharmaceutical company Mithridion recently secured $1.25 million in funding from Venture Investors, The State of Wisconsin Investment Board, and Rocket Venture Fund. Mithridion is developing drug candidates that focus on serious Central Nervous System disorders, including Alzheimer’s disease.